Belite Bio
BLTE
69 hedge funds and large institutions have $1.15B invested in Belite Bio in 2025 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 4 closing their positions.
900% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 4
581% more capital invested
Capital invested by funds: $169M → $1.15B (+$984M)
103% more funds holding
Funds holding: 34 → 69 (+35)
70% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 10
11.98% more ownership
Funds ownership: 7.19% → 19.17% (+12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$359M |
| 2 |
Millennium Management
New York
|
+$63.7M |
| 3 |
RI
RTW Investments
New York
|
+$47.7M |
| 4 |
PA
Perceptive Advisors
New York
|
+$43.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$33.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$52.4M |
| 2 |
VPC
Vestal Point Capital
New York
|
-$23.1M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$20.1M |
| 4 |
JP Morgan Chase
New York
|
-$1.16M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$1.08M |
BLTE Hedge Fund Activity: Q4 2025 in Review
69 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q4 2025, worth a combined $1.15B — up 581% from $169M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new BLTE positions and 4 closed out — a net gain of 36 holders — while 17 added to existing stakes and 10 trimmed.
The largest buyer was Darwin Global Management, opening a new position worth an estimated $359M. The largest seller was RA Capital Management, cutting an estimated $52.4M.
- 69 institutional investors held Belite Bio (BLTE) as of Q4 2025, up from 34 in Q3 2025.
- Funds reported $1.15B of Belite Bio stock for Q4 2025, up 581% quarter-over-quarter.
- 40 funds opened new Belite Bio positions in Q4 2025 and 4 closed out, a net change of +36 holders.
- The largest Belite Bio buyer in Q4 2025 was Darwin Global Management, an estimated $359M added.
- The largest Belite Bio seller in Q4 2025 was RA Capital Management, an estimated $52.4M sold.
Based on aggregated 13F filings for Q4 2025.